Open AccessReverse remodeling and arrhythmic burden reduction in a patient with an implantable cardioverter defibrillator treated with sacubitril/valsartan: Case report
Author(s) -
Corrado Egle,
Saladino Antonino,
Morgante Giusy,
Mignano Antonino,
Nugara Cinzia,
Novo Giuseppina,
Coppola Giuseppe
Publication year - 2020
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2655
Subject(s) - sacubitril, valsartan , medicine , valsartan , sacubitril , enalapril , cardiology , implantable cardioverter defibrillator , ventricular remodeling , heart failure , angiotensin converting enzyme , blood pressure
Sacubitril/valsartan has been shown to reduce cardiovascular mortality and hospitalizations in patients with HFrEF when compared to enalapril. There are also some evidences of its potential antiarrhythmic effects. We present a report where we found a relation between reverse ventricular remodeling and arrhythmic reduction in a patient treated with sacubitril/valsartan.